Ikehara M - Search Results

1

Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas.

Ito H, Oshita F, Kameda Y, Suzuki R, Ikehara M, Arai H, Mitsuda A, Saito H, Yamada K, Noda K, Nakayama H. Ito H, et al. Among authors: ikehara m. Oncol Rep. 2002 Jan-Feb;9(1):119-23. Oncol Rep. 2002. PMID: 11748468

2

Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.

Ikehara M, Oshita F, Kameda Y, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A. Ikehara M, et al. Oncol Rep. 2002 Jul-Aug;9(4):835-8. Oncol Rep. 2002. PMID: 12066218

3

Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer.

Oshita F, Kameda Y, Ikehara M, Tanaka G, Yamada K, Nomura I, Noda K, Shotsu A, Fujita A, Arai H, Ito H, Nakayama H, Mitsuda A. Oshita F, et al. Among authors: ikehara m. Anticancer Res. 2002 Mar-Apr;22(2B):1065-70. Anticancer Res. 2002. PMID: 12168902

4

Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-beta.

Oshita F, Sekiyama A, Suzuki R, Ikehara M, Yamada K, Saito H, Noda K, Miyagi Y. Oshita F, et al. Among authors: ikehara m. Oncol Rep. 2003 Jan-Feb;10(1):105-8. Oncol Rep. 2003. PMID: 12469153

5

Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung.

Ikehara M, Oshita F, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A, Kameda Y. Ikehara M, et al. Oncol Rep. 2003 Jan-Feb;10(1):137-9. Oncol Rep. 2003. PMID: 12469159

6

Genome-wide cDNA microarray screening to correlate gene expression profile with survival in patients with advanced lung cancer.

Ikehara M, Oshita F, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y. Ikehara M, et al. Oncol Rep. 2004 May;11(5):1041-4. Oncol Rep. 2004. PMID: 15069544

7

Phase II study of OK-432 intrapleural administration followed by systemic cisplatin and gemcitabine for non-small cell lung cancer with pleuritis carcinomatosa.

Ikehara M, Oshita F, Suzuki R, Saitoh H, Yamada K, Noda K. Ikehara M, et al. J Exp Ther Oncol. 2004 Apr;4(1):79-83. J Exp Ther Oncol. 2004. PMID: 15255294 Clinical Trial.

8

Prognostic impact of survivin, cyclin D1, integrin beta1, and VEGF in patients with small adenocarcinoma of stage I lung cancer.

Oshita F, Ito H, Ikehara M, Ohgane N, Hamanaka N, Nakayama H, Saito H, Yamada K, Noda K, Mitsuda A, Kameda Y. Oshita F, et al. Among authors: ikehara m. Am J Clin Oncol. 2004 Aug;27(4):425-8. doi: 10.1097/01.coc.0000128864.15609.5b. Am J Clin Oncol. 2004. PMID: 15289739

9

Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.

Oshita F, Ikehara M, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y. Oshita F, et al. Among authors: ikehara m. J Exp Ther Oncol. 2004 Jul;4(2):155-60. J Exp Ther Oncol. 2004. PMID: 15500010

10

Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer.

Oshita F, Nishio K, Kameda Y, Mitsuda A, Ikehara M, Tanaka G, Yamada K, Nomura I, Noda K, Arai H, Ito H, Nakayama H. Oshita F, et al. Among authors: ikehara m. Oncol Rep. 2000 Nov-Dec;7(6):1225-8. doi: 10.3892/or.7.6.1225. Oncol Rep. 2000. PMID: 11032919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters